MedeFinance, Inc. (Mede), the leading healthcare performance analytics company, announced that it has successfully attained HFMA's Peer Review approval status. This rigorous process is designed to provide healthcare financial managers with an objective third party evaluation of products and services used in the healthcare finance workplace. The Peer Review process consists of a rigorous eleven-step, high-level screening process by a peer review panel consisting of current customers, prospects who have not made a purchase, and expert HFMA Peer Review Board members. Peer Review status approval of the product or service and its performance claims are based on the following criteria: effectiveness, quality and usability, price, value, and customer and technical support.

Mede's Peer Review status will benefit healthcare organizations considering Mede by providing a valuable time savings in their search and evaluation of performance analytics solutions, and can ultimately improve Mede clients' patient experience through the implementation of solutions and services with demonstrated superior results. The approved status means healthcare organizations benefit from the research and trials completed by the Peer Review board and can be assured of broad market research.

"We are extremely pleased to have met the stringent standards of the HFMA Peer Review process for our healthcare analytics solutions," said Mede CEO Mike Gallagher. "It is gratifying to know that our clients who participated in the evaluation, as well as independent experts, gave our healthcare analytics solutions high marks for their quality, ease of use and exceptional return on investment."

About Mede

Mede enables healthcare organizations to achieve improved outcomes in clinical, financial and operational performance by providing performance analytics delivered on demand and enhanced by healthcare-experienced client teams. Over 700 healthcare organizations in the U.S. and U.K. have experienced rapid and sustainable value from Mede analytics solutions with low total cost of ownership. The company has been recognized by Inc. magazine as one of the 500 fastest-growing privately held companies in the U.S. To find out more about Mede, visit medefinance.

Mede